Belite Bio (BLTE)
(Real Time Quote from BATS)
$66.25 USD
-3.54 (-5.07%)
Updated Aug 5, 2025 12:56 PM ET
4-Sell of 5 4
C Value C Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BLTE 66.25 -3.54(-5.07%)
Will BLTE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BLTE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLTE
New Strong Sell Stocks for August 4th
New Strong Sell Stocks for July 22nd
BLTE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BLTE
Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results ...
Belite Bio Inc (BLTE) Announces Upcoming Webcast for Q2 2025 Financial Results | BLTE stock news
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference | BLTE Stock News
Belite Bio Inc (BLTE) to Participate in BTIG Virtual Biotechnology Conference | BLTE stock news
Bullish Two Hundred Day Moving Average Cross - BLTE